Development of building projects
VERNIX PHARMA AS
Revenue 2025
NOK 0
Operating profit
NOK −30,000
Equity
NOK 154,000
Incorporated
1994
Share capital
NOK 243,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 0 | |
| Total operating costs | 30k | |
| Operating profit (EBIT) | −30k | |
| Net financial items | −605 | |
| Profit for the year | −31k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 157k | |
| of which current assets | 57k | |
| Equity | 154k | |
| Total liabilities | 3k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.